---
figid: PMC4859220__nihms-780239-f0001
figtitle: Mechanisms of action of the PD-L1 and PD-1 pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4859220
filename: nihms-780239-f0001.jpg
figlink: /pmc/articles/PMC4859220/figure/F1/
number: F1
caption: Mechanisms of action of the PD-L1 and PD-1 pathway. Tumor cells, APCs, and
  other cells express high levels of PD-L1. Engagement of PD-L1+ cells with T cells
  may induce T-cell apoptosis, anergy, functional exhaustion, or IL-10 production.
papertitle: 'PD-L1 (B7-H1) and PD-1 Pathway Blockade for Cancer Therapy: Mechanisms,
  Response Biomarkers and Combinations.'
reftext: Weiping Zou, et al. Sci Transl Med. ;8(328):328rv4-328rv4.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8215649
figid_alias: PMC4859220__F1
figtype: Figure
redirect_from: /figures/PMC4859220__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4859220__nihms-780239-f0001.html
  '@type': Dataset
  description: Mechanisms of action of the PD-L1 and PD-1 pathway. Tumor cells, APCs,
    and other cells express high levels of PD-L1. Engagement of PD-L1+ cells with
    T cells may induce T-cell apoptosis, anergy, functional exhaustion, or IL-10 production.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD274
  - RGMB
  - PDCD1LG2
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - IL10
  - CD80
---
